Iba – Acquisition of Own Shares
27 Août 2021 - 07:15PM
Iba – Acquisition of Own Shares
Immediate Release – August 27th, 2021
Louvain-la-Neuve, Belgium, August
27th, 2021 - In accordance with article 8:4 of
the Royal Decree of 29 April 2019 executing the Belgian Code on
Companies and Associations, Ion Beam Applications SA (“IBA”) hereby
discloses information in relation to its share buyback program
announced on June 29th, 2021.
Under this program, IBA has requested a
financial intermediary to repurchase up to 250.000 IBA ordinary
shares on its behalf under the terms of a discretionary mandate
agreement with validity until December 30th, 2021, effective as
from June 30th, 2021, to cover the company’s obligations under a
long term incentive plan for certain members of its personnel.
In the framework of this share buyback program,
IBA repurchased 18.149 IBA shares on Euronext Brussels in the
period from August 20th, 2021 up to and including August 26th,
2021, as follows:
These transactions include the purchase of a block of shares on
the central order book of Euronext Brussels (XBRU):
- On August 25th at 11.18 AM: 10.000 shares at a price of 16,80
EUR/share;
The total number of shares purchased under this
program therefore amounts to 165.943. As a result, the
current situation with respect to treasury shares (held directly by
IBA SA and indirectly through its subsidiary IBA Investments SCRL)
is the following:
About IBAIBA (Ion Beam
Applications S.A.) is a global medical technology company focused
on bringing integrated and innovative solutions for the diagnosis
and treatment of cancer. The company is the worldwide technology
leader in the field of proton therapy, considered to be the most
advanced form of radiation therapy available today. IBA’s proton
therapy solutions are flexible and adaptable, allowing customers to
choose from universal full-scale proton therapy centers as well as
compact, single room solutions. In addition, IBA has a radiation
dosimetry business and develops particle accelerators for the
medical world and industry. Headquartered in Belgium and employing
about 1,500 people worldwide, IBA has installed systems across the
world.
IBA is listed on the pan-European stock exchange
NYSE EURONEXT (IBA: Reuters IBAB.BR and Bloomberg IBAB.BB). More
information can be found at www.iba-worldwide.com
Contact person
IBA Christian Matton,Chief
Legal Officershareholderrelations@iba-group.com
- Press release EN AOOS 20210827
Ion Beam Applications (EU:IBAB)
Graphique Historique de l'Action
De Fév 2024 à Mar 2024
Ion Beam Applications (EU:IBAB)
Graphique Historique de l'Action
De Mar 2023 à Mar 2024